France Viscosupplementation Market Size & Outlook, 2025-2033

The viscosupplementation market in France is expected to reach a projected revenue of US$ 190.4 million by 2033. A compound annual growth rate of 8.1% is expected of France viscosupplementation market from 2025 to 2033.
Revenue, 2024 (US$M)
$91.9
Forecast, 2033 (US$M)
$190.4
CAGR, 2025 - 2033
8.1%
Report Coverage
France

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France viscosupplementation market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France viscosupplementation market highlights

  • The France viscosupplementation market generated a revenue of USD 91.9 million in 2024 and is expected to reach USD 190.4 million by 2033.
  • The France market is expected to grow at a CAGR of 8.1% from 2025 to 2033.
  • In terms of segment, single injection was the largest revenue generating product in 2024.
  • Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.


Viscosupplementation market data book summary

Market revenue in 2024USD 91.9 million
Market revenue in 2033USD 190.4 million
Growth rate8.1% (CAGR from 2025 to 2033)
Largest segmentSingle injection
Fastest growing segmentSingle Injection
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSingle Injection, Three Injection, Five Injection
Key market players worldwideDePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG


Other key industry trends

  • In terms of revenue, France accounted for 1.7% of the global viscosupplementation market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany viscosupplementation market is projected to lead the regional market in terms of revenue in 2033.
  • Denmark is the fastest growing regional market in Europe and is projected to reach USD 54.6 million by 2033.

Single injection was the largest segment with a revenue share of 49.08% in 2024. Horizon Databook has segmented the France viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2021 to 2033.


The prevalence of osteoarthritis is expected to increase in France due to increasing proportion of elderly population. The overall social and demographical changes have resulted in increased healthcare burden on the country, forcing it to reduce the healthcare budget. In 2014, there were more than 12 HA derivatives are on the market, classified as devices, except in the case of Hyalgan, which has been classified as a drug with market authorization in knee osteoarthritis.

In 2000, Biomatrix reported that the Ministère de l' Emploi et de la Solidarité, France Ministry of Health agreed to reimburse the high-molecular-weight viscoelastic devices with three intraarticular injections administered for over a 15-day period. There are various manufacturers operating in the market who are in the process of introducing new products.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viscosupplementation Market Companies

Name Profile # Employees HQ Website
Lifecore Biomedical Inc View profile 459 3515 Lyman Boulevard, Chaska, MN, United States, 55318 https://www.lifecore.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Anika Therapeutics Inc View profile 357 32 Wiggins Avenue, Bedford, MA, United States, 01730 https://www.anika.com
LG Chem View profile 10001+ Seoul, Seoul-t'ukpyolsi, South Korea, Asia https://www.lgchem.com
Smith & Nephew PLC View profile 18452 Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE https://www.smith-nephew.com
DePuy Synthes View profile 5001-10000 Raynham, Massachusetts, United States, North America https://depuysynthes.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

France viscosupplementation market size, by end use, 2021-2033 (US$M)

France Viscosupplementation Market Outlook Share, 2024 & 2033 (US$M)

France viscosupplementation market size, by end use, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online